| Product name |
CreaVax-RCC |
| Physical appearance |
Colorless solution with suspension of ivory colored dendritic cells |
| Efficacy and effectiveness |
Metastatic renal cell carcinoma for which nephrectomy can be performed |
| Application method and dose |
Although 5x107 cells (1 vial of CreaVax-RCC) is to be administered 4 times at the interval of once every 2 weeks in principle in order to induce anti-cancer immunity in the metastatic renal cell carcinoma patient through intra dermal injection, the duration of administration may be adjusted in accordance with the decision of the physician |
| Packing unit |
1 vial (2 mL) X packing unit of our company |
| Storage method shelf life |
At temperatures below -150℃, 6 months after the manufacturing of the sealed container |
> Product > Immune cell Therapeutic Agent > CreaVax-RCC